DOI:
10.1055/s-00000145
Dialyse aktuell
LinksClose Window
References
de Jonge H, de Loor H, Verbeke K. et al
In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.
Clin Pharmacol Ther 2012;
92: 366-375 doi:10.1038/clpt.2012.109
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.